Gene · 1827
Papers1,437
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,437
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circ_0001490/miR-330-3p/RCAN1 Signaling Defines a ceRNA Network Associated with Rheumatic Heart Disease Progression. | Ann Clin Lab Sci | 2026 | 42790940 | PubTator, text mining | PubMed |
| Oxidative stress induces porcine RCAN1-1L to promote mitophagy and enhance PRRSV replication. | Dev Comp Immunol | 2026 | 42763026 | PubTator, text mining | PubMed |
| Advanced esophageal adenocarcinoma in a pediatric patient with Down syndrome: a rare case report and literature review. | Ann Med Surg (Lond) | 2026 | 42725202 | PubTator, text mining | PubMed |
| Integrated Bulk and Single-Cell Transcriptomic Analysis Identifies a Reproducible SASP-Related Three-Gene Panel and Prioritizes CFB as a Fibroblast-Associated Marker in Rheumatoid Arthritis. | Genes (Basel) | 2026 | 42510776 | PubTator, text mining | PubMed |
| First- and Second-Trimester Cardiovascular Anomalies in Trisomy 21 Fetuses: Anatomy, Embryology, Genetics and Imaging. | J Pers Med | 2026 | 42506084 | PubTator, text mining | PubMed |
| The Role of Genetic Alterations in the Emergence of Alzheimer's Disease in Down Syndrome: A Review. | Eur J Neurosci | 2026 | 42442802 | PubTator, text mining | PubMed |
| SUMO3/RUNX1/AIRE/RCAN1 and DNMT3L/DYRK1A/Let-7c-5p/VEGF axes: immune dysregulation and genetic susceptibility as pulmonary risk factors in Down syndrome. | 3 Biotech | 2026 | 42245386 | PubTator, text mining | PubMed |
| RNA-binding protein RCAN1.1L modulates ATF2 mRNA stability to promote mitochondrial fission in acute ischemic stroke. | Cell Death Dis | 2026 | 42129133 | PubTator, text mining | PubMed |
| Mechanically Induced Adaptive Self-Growing Protein Hydrogel. | Adv Mater | 2026 | 42068201 | PubTator, text mining | PubMed |
| Peripheral blood biomarkers RCAN1, Clusterin, RAGE, and malondialdehyde for early diagnosis and progression of Alzheimer's disease. | BMC Med | 2026 | 42045900 | PubTator, text mining | PubMed |
| Calcium silicate cement with phosphate-based glass for enhanced osteogenic activity and mechanical strength. | Clin Oral Investig | 2026 | 42018191 | PubTator, text mining | PubMed |
| DYRK1A and Parkinson's disease, facts and hypotheses. | Neurobiol Dis | 2026 | 41991085 | PubTator, text mining | PubMed |
| A pathogenic Tau mutation drives autophagy-lysosome dysfunction that limits Tau degradation in a model of frontotemporal dementia. | Nat Commun | 2026 | 41916975 | PubTator, text mining | PubMed |
| Advancements in Therapy for Alzheimer's Disease Based on the Cerebral Lymphatic System. | Degener Neurol Neuromuscul Dis | 2026 | 41878054 | PubTator, text mining | PubMed |
| RNA-Seq of Gingival Fibroblasts Grown on Collagen Membranes and Hyaluronic Acid. | J Funct Biomater | 2026 | 41745519 | PubTator, text mining | PubMed |
| The Evolution, Oligomerization, Function, and Action Mechanism of α2-Macroglobulin. | Cells | 2026 | 41744796 | PubTator, text mining | PubMed |
| First 2-year experience of nationwide newborn screening for severe forms of T and B cell immunodeficiency: 2.3 million newborns analyzed using TREC and KREC in Russia. | Front Immunol | 2026 | 41727503 | PubTator, text mining | PubMed |
| CREM regulates the tumor immune microenvironment and predicts prognosis in thyroid carcinoma. | Transl Cancer Res | 2026 | 41674925 | PubTator, text mining | PubMed |
| APP-C31 pathology as a target in neurodegenerative diseases. | J Biomed Sci | 2026 | 41639863 | PubTator, text mining | PubMed |
| Calcineurin-NFAT-DSCR1.4 signaling as druggable axis in Gαq-R183Q-driven capillary malformations. | Angiogenesis | 2026 | 41636844 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1827/papers